Impacts of regulatory options in independent dispute resolution on costs under the No Surprises Act

In October, CMS further outlined key parameters for the process of independent dispute resolution (IDR) available for providers and payers who cannot reach agreement on payment through direct negotiations. We review the federal statute and how it compares to existing state IDR programs. We also determined several payment cost measures to evaluate the potential financial effect of various prevailing IDR payment awards.

This report was commissioned by UnitedHealth Group (UHG).